Corline Biomedical
9,4
SEK
0 %
Mindre end 1K følgere
CLBIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
0%
-16,07%
+7,06%
+18,99%
+16,05%
-29,32%
-27,41%
-25,35%
-4,97%
Corline Biomedical is active in the pharmaceutical industry. The company works with the substance heparin and has developed a portfolio of drug candidates for use in connection with organ and cell transplantation. The company sells its proprietary product CHS™ to medical technology customers, and is developing Renaparin® for use in regenerative medicine and organ transplantation. The headquarters are located in Uppsala.
Læs mereMarkedsværdi
230,21 mio. SEK
Aktieomsætning
20,47 t SEK
Omsætning
9,78 mio.
EBIT %
-236,91 %
P/E
-
Udbytteafkast, %
-
Finanskalender
8.5
2025
Delårsrapport Q1'25
15.5
2025
Generalforsamling '25
26.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Redeye: Redeye Initiates Coverage of Corline Biomedical
Corline Biomedical AB: Will present at investor event hosted by Aktiespararna on June 3rd in Stockholm
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools